Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC (TUMORIN)

NCT05332925 is registered in ClinicalTrials.gov with Jun Zhang, MD, PhD as lead sponsor.

NCT NCT05332925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05332925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC (TUMORIN)
Lead sponsor
Jun Zhang, MD, PhD
Phase
Observational
Overall status
Recruiting
Start date
July 21, 2022
Completion date
February 28, 2027
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, nsclc, nsclc stage iv